益丰药房：不向下修正“益丰转债”转股价格

Core Viewpoint - Yifeng Pharmacy announced that it will not lower the conversion price of its "Yifeng Convertible Bonds" during the upcoming three-month period, even if the stock price triggers the adjustment clause [1] Summary by Sections Company Decision - The company held its 23rd meeting of the fifth board of directors on October 15, 2025, where it approved the proposal not to lower the conversion price of the "Yifeng Convertible Bonds" [1] - The decision means that from October 16, 2025, to January 15, 2026, the conversion price will remain unchanged, regardless of stock price movements [1] Future Considerations - The next period for triggering the conversion price adjustment clause will start from January 16, 2026 [1] - If the stock price triggers the adjustment clause again, the board will convene to decide whether to exercise the right to lower the conversion price [1]